ALEXANDER I SPIRA M.D. NPI 1902874514

NPI Details

Alexander I Spira, M.D. is a medical oncology internal medicine in Fairfax, VA with 28 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Alexander I Spira, M.D. NPI is 1902874514. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:1997

The provider's business location address is:

8613 LEE HWY # 200N
FAIRFAX, VA
ZIP 22031-171
Phone: (032) 083-1557
Fax: (703) 280-9596

The NPI 1902874514 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, azacitidine, 1 mg (HCPCS:J9025)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, pemetrexed, not otherwise specified, 10 mg (HCPCS:J9305)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Nephelometry, test method using light (HCPCS:83883)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Protein measurement, serum (HCPCS:84165)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Magnesium level (HCPCS:83735)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Unclassified drugs (HCPCS:J3490)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Urinalysis, manual test (HCPCS:81002)
• Phosphate level (HCPCS:84100)
• Uric acid level, blood (HCPCS:84550)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Bilirubin level, direct (HCPCS:82248)
• Folic acid level, serum (HCPCS:82746)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Thyroid hormone, t3 measurement, free (HCPCS:84481)
• Administration of influenza virus vaccine (HCPCS:G0008)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)

The enumeration date for this NPI number is 3/9/2006 and was last updated on 11/11/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.